The Op-Ed: FDA panels: too many conflicts or too little expertise? -

June 2013. Should FDA Advisory Committee members be allowed to have financial conflicts of interest regarding the approval of medical products? Diana Zuckerman discusses how financial ties to pharmaceutical companies can influence the voting and discussion on drug and medical device approvals, and how misunderstandings of statistics and the value of clinical trials can lead to the approval of dangerous products.

Maryland playground closes due to possible toxicity -

NBC4 Washington, June 13, 2013. Diana Zuckerman with the Cancer Prevention and Treatment Fund said parents had good reason to be concerned about rubber mulch. “Rubber mulch contains phthalates, which are chemicals that affect hormones, and other chemicals that are known to be harmful to our health,” Zuckerman said.

Angelina Jolie’s decision -

Did Angelina Jolie make the right decision? And should that influence other women? Our president Dr. Diana Zuckerman explains why Angelina’s risk of breast cancer is lower than she was told and what the implications are for you.